16 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Why Cabot (CBT) is a Top Value Stock for the Long-Term https://www.zacks.com/stock/news/2247346/why-cabot-cbt-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2247346 Mar 28, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick https://www.zacks.com/stock/news/2239245/are-you-a-value-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2239245 Mar 12, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Better Therapeutics' (BTTX) CBT Gains FDA's Breakthrough Status https://www.zacks.com/stock/news/2230299/better-therapeutics-bttx-cbt-gains-fda-s-breakthrough-status?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2230299 Feb 22, 2024 - Better Therapeutics' (BTTX) novel CBT platform attains the FDA's breakthrough device designation to improve patient care in the treatment of liver and metabolic diseases.
Why Cabot (CBT) is a Top Momentum Stock for the Long-Term https://www.zacks.com/stock/news/2230218/why-cabot-cbt-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2230218 Feb 22, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Are You Looking for a High-Growth Dividend Stock? https://www.zacks.com/stock/news/2215152/are-you-looking-for-a-high-growth-dividend-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-2215152 Jan 24, 2024 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Cabot (CBT) have what it takes? Let's find out.
Best Value Stocks to Buy for January 15th https://www.zacks.com/commentary/2210014/best-value-stocks-to-buy-for-january-15th?cid=CS-ZC-FT-zacks_1_rank_additions|value_additions-2210014 Jan 15, 2024 - RGA, PAX and CBT made it to the Zacks Rank #1 (Strong Buy) value stocks list on January 15, 2024.
Arkema (ARKAY) Backs Tiamat for Lithium-Free Battery Innovation https://www.zacks.com/stock/news/2209961/arkema-arkay-backs-tiamat-for-lithium-free-battery-innovation?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2209961 Jan 15, 2024 - Arkema (ARKAY) invests in Tiamat, accelerating the development of lithium-free solutions and supporting the construction of a dedicated 5 GWh Giga-factory in France.
New Strong Buy Stocks for January 15th https://www.zacks.com/commentary/2208916/new-strong-buy-stocks-for-january-15th?cid=CS-ZC-FT-zacks_1_rank_additions-2208916 Jan 15, 2024 - CBT, BROS, WRK, ROCK and CBOE have been added to the Zacks Rank #1 (Strong Buy) List on January 15, 2024.
ArcelorMittal (MT) to Restart Bosnia Plant After Two-Month Halt https://www.zacks.com/stock/news/2208986/arcelormittal-mt-to-restart-bosnia-plant-after-two-month-halt?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2208986 Jan 11, 2024 - ArcelorMittal (MT) plans to restart its Bosnia plant after a November shutdown due to declining steel demand in Europe, influenced by the Ukraine war and rising costs.
BASF (BASFY) & Stena Partner for Europe's EV Battery Recycling https://www.zacks.com/stock/news/2208437/basf-basfy-stena-partner-for-europe-s-ev-battery-recycling?cid=CS-ZC-FT-analyst_blog|company_news_-_corporate_actions-2208437 Jan 10, 2024 - BASF (BASFY) and Stena Recycling will create a circular battery recycling system for European electric vehicles, emphasizing high metal recovery rates and a reduced carbon footprint.

Pages: 12

Page 1